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Introduction
As early as 2002, the International Ethics Committee of 
the Human Genome Organization (HUGO) stated that 
human genomic databases should be considered as global 
public goods [1]. In this statement, global public goods 
were defined as goods ‘whose scope extends worldwide, 
are enjoyable by all with no groups excluded, and when 
consumed by one individual, are not depleted for others’ 
[2]. Buttressed by the Bermuda Principles of 1996 [2] and 
mirrored  in  the  Fort  Lauderdale  rules  of  2003  [3],  the 
common philosophy of sharing resources was reaffirmed 
in  the  2008  International  Summit  on  Proteomics  Data 
Release and Sharing Policy in Amsterdam [4] and in the 
Toronto International Data Release Workshop of 2009 [5].
Finally,  in  January  2011,  17  major  health  funding 
agencies  signed  a  joint  statement  on  sharing  research 
data to promote and improve public health [6]. However, 
the  challenge  is  to  take  these  fundamental  values  of 
sharing and access and to develop guiding principles 
and  procedures  that  can  be  used  as  a  basis  for 
emerging practice.
To begin, we consider data sharing as a form of data 
processing as defined by the EU Directive 95/46/EC on 
data  protection  [7].  In  this  directive,  data  processing 
refers  to:  ‘any  operation  or  set  of  operations  which  is 
performed  upon  personal  data,  whether  or  not  by 
automatic means, such as […] retrieval, consultation, use, 
disclosure  by  transmission,  dissemination  or  otherwise 
making  available  […]’  [7].  Data  can  include  raw  data, 
genotype/phenotype  data  and  data  included  within 
governmental health administrative databases. Theoreti­
cally, personal medical records could be subsumed under 
this  term,  but  we  have  not  specifically  addressed  such 
data because their regulation is jurisdiction­specific. The 
code’s principles, however, remain pertinent to such data. 
For  the  terms  ‘coded’  and  ‘anonymized’,  we  use  the 
definitions  provided  by  the  2007  International  Con  fer­
ence on Harmonization [8].
Data sharing is regarded as essential for enabling and 
promoting genomic research in a way that will maximize 
the  benefits  to  public  health  [6]  and  society  [9].  All 
countries, funders and investigators are aware of the need 
for  research  ethics  and  governance  mechanisms  in 
research, but currently there is little policy guidance that 
is  specific  to  the  international  sharing  of  genomic 
research data. In view of the recent calls for the develop­
ment of common principles applying to data access and 
use [7,10], Public Population Project in Genomics (P3G) 
[11],  European  Network  for  Genetic  and  Genomic 
Epidemiology  (ENGAGE)  [12]  and  Centre  for  Health, 
Law and Emerging Technologies (HeLEX) [13] are work­
ing  on  an  international  data  sharing  Code  of  Conduct 
(Box  1).  This  has  a  dual  purpose:  to  elucidate  shared 
values and to provide guidance on the basic obligations 
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© 2011 BioMed Central Ltdflowing  from  it.  Given  the  varied  disciplinary  back­
grounds of researchers working in genomic research, it 
can no longer be presumed that all the scientists engaged 
in data sharing are bound by the same medical or other 
professional deontological frameworks or can be subject 
to disciplinary action for a breach. Therefore, the pro­
posed international Code of Conduct for data sharing in 
genomic research seeks to provide common guidance on 
the basis of two fundamental values: (i) mutual respect 
and  trust  between  scientists,  stakeholders  and  partici­
pants;  and  (ii)  a  commitment  to  safeguarding  public 
trust, participation and investment. The elaboration and 
eventual implementation of such a code should be the 
object of ongoing discussion and will begin with a series 
Box 1. International Data Sharing Code of Conduct
Preamble
This proposed international data sharing Code of Conduct seeks to promote greater access to and use of data in ways that are (as 
proposed by the joint statement by funders of health research [6]):
‘Equitable: any approach to the sharing of data should recognize and balance the needs of researchers who generate and use data, other 
analysts who might want to reuse those data, and communities and funders who expect health benefits to arise from research.
Ethical: all data sharing should protect the privacy of individuals and the dignity of communities, while simultaneously respecting the 
imperative to improve public health through the most productive use of data.
Efficient: any approach to data sharing should improve the quality and value of research and increase its contribution to improving public 
health. Approaches should be proportionate and build on existing practice and reduce unnecessary duplication and competition.’
Principles and Procedures
1. Quality
Irrespective of the discipline, scientists involved in data sharing should be bona fide researchers.
Proof of academic or other recognized peer reviewed standing is essential.
Harmonization of data collection and archiving methods and tools ensures validation of scientific quality.
Collaboration promotes efficiency, sustainability and comparability.
2. Accessibility
Facilitation of both the deposit of data and secure access to data are the foundations of data sharing.
Curators of databases should promote sharing to generate maximum value.
Harmonization of deposit, access procedures and use promotes accessibility, equity and transparency.
3. Responsibility
Responsible governance should be shared between funders, generators and users of data.
Investments in databases require coordination, strategy and long-term core funding.
Mechanisms for building interoperability should be encouraged and appropriate management anticipated.
Capacity building and recognition of all the data generators contributes to best practices.
4. Security
Trust and the promotion of data sharing rely on data management and security mechanisms and also on oversight of their functioning.
Mechanisms for identifying and tracking data generators and users should be international.
5. Transparency
Key policies on publications, intellectual property, and industry involvement should be public.
Websites that are accessible to the general public serve to provide feedback on progress and general results.
6. Accountability
Inter-agency co-operation and funding fosters streamlined and efficient monitoring and good governance.
Provisions should be made for ongoing public engagement that is tailored to the nature of the database and local cultures.
7. Integrity
Mutual respect between all stakeholders is founded on personal and professional integrity.
Prevention of harms and anticipation of public concerns and scientific needs through foresight mechanisms encourage the development 
of common, prospective policies.
Irresponsible research practices should be reported.
Sanctions for breach of this Code or of other legal or ethical obligations must be clear.
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and national fora.
Principles and procedures: background and 
rationale
Although we are not attempting to prioritize or in any 
way create a hierarchy among various principles in the 
field of data sharing, they all derive from a shared belief 
in maximizing both scientific quality (Box 1, point 1) and 
public benefit through rapid release and public accessi­
bility to data (Box 1, point 2) [14].
The  assurance  of  quality  is  sine  qua  non  for  ethical 
science. Making it an explicit requirement reiterates its 
importance  and  mandates  comparison,  validation  and 
replication,  thereby  ensuring  appropriate  and  common 
standard operating procedures and the use of accredited 
facilities. Prospectively harmonizing procedures to facili­
tate interoperability and comparability is likely to promote 
such quality and accessibility.
There  is  no  doubt  that  maximizing  public  benefit, 
investment and participation is facilitated through data 
sharing. Not only should access be equitable for research­
ers  in  both  the  public  and  private  sectors,  but  ethics 
reviewers should have the proper training and tools to 
evaluate international requests. The datasets themselves 
may  be  derived  from  the  contributions  of  multiple 
sources  from  different  countries  and  projects.  The 
current legal and ethical constraints and bottlenecks to 
access are obvious. Indeed, multiplicity of ethics review 
may well be the Achilles heel for efficient sharing.
The  tripartite  responsibility  of  the  data  producers, 
users and funders lays the foundation for data sharing 
(Box 1, point 3). We see data sharing, which is often a 
condition of funding, as part of the efficient and proper 
stewardship of public funds. It also binds eventual users 
in the recognition of a just return on public investment 
and participation. This responsibility is chiefly expressed 
both  in  the  security  mechanisms  that  translate  the 
principle into the construction of information technology 
tools and firewalls and in the governance framework.
Security mechanisms
Security mechanisms (Box 1, point 4) go well beyond the 
application  of  firewalls  or  de­identification  techniques, 
such as coding or anonymization. Indeed, unique, digital 
identifiers (IDs) for biobanks [15,16] and for researchers 
[17] have been proposed not only for security purposes 
but to facilitate access. Such IDs would enable verification 
and  validation  of  the  identities  and  credentials  of 
researchers by institutions and would become a mecha­
nism for allowing, tracking and auditing access, as well as 
attributing contributions.
Digital identifier systems allow data tracing and pros­
pec  tively  limit  the  potential  for  malicious  activities 
involving  re­identification  of  participants.  This  trans­
parency  of  data  flow,  access  and  use  also  curtails  the 
possibility of pre­publication scooping between producers 
and users (Box 1, point 5). Pre­publication data release 
depends  on  the  respect  by  users  and  journals  of 
publication moratoria that allow data producers to share 
data openly but provides a period of time to analyze and 
publish  their  own  data  before  secondary  users  do  so. 
Proper  acknowledgement  of  the  use  of  data  resources 
also allows funders to track their ‘investments’. It allows 
the public to see that their altruistic participation has led 
to  fruitful  scientific  endeavors.  Most  importantly,  data 
users agree not to use intellectual property protection in 
ways that would prevent or block access to, or use of, any 
element of the dataset or any conclusion drawn directly 
from it [18]. This does not prevent further research with 
attendant  intellectual  property  rights  in  downstream 
discoveries provided that the best practices for licensing 
policies for genomic inventions are followed.
Governance framework
Good governance underpins a system of data sharing that 
depends on trust. Approaches to governance necessarily 
vary  between  contexts  and  countries.  Irrespective  of 
these  differences,  governance  should  be  flexible  in  the 
oversight and monitoring systems put in place. This is 
crucial because public trust, which is increasingly trans­
lated through broad consents, is counterbalanced by both 
security  systems  and  governance.  It  could  be  asked 
whether  in  considering  the  longevity  of  large  inter­
national datasets, including samples, separate governance 
models should be developed as distinct from local insti­
tutional mechanisms or those applicable to the oversight 
of clinical trials.
Good  governance  assures  the  public  and  funders  of 
proper accountability and ethics review (Box 1, point 6). 
Although local laws and ethics review systems vary, the 
ethics  norms  and  biobank  policies  applicable  to  large 
data repositories are beginning to emerge [19,20]. These 
common  norms  are  increasingly  mirrored  in  model 
material transfer and access agreements [10]. Contractual 
in nature, they serve to bind researchers and their institu­
tions. Implicit in such agreements are the very principles 
under discussion here. By making them explicit by using 
such  contracts,  researchers,  policymakers  and  ethics 
com  mittees  have  tools  to  work  with  that  are  more 
transparent. For scientific integrity (Box 1, point 7) to be 
viable, discussion on the nature of such principles and 
their  procedural  translation  in  different  contexts  will 
necessarily  vary.  Nevertheless,  mutual  respect  between 
all stakeholders and participants can be built on these 
fundamental  principles  and  procedures.  Integrity  also 
entails  the  prevention  of  harms,  anticipation  of  public 
concerns and scientific needs as well as the reporting of 
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appropriate sanctions [21].
Most  importantly,  ongoing  communication  with  the 
public  on  the  ‘reality’  of  data  sharing  principles  and 
procedures  is  essential.  Thus,  lay  summaries  of  the 
research proposals accessing and using data repositories 
should be publicly posted. Although there is no personal 
benefit to participants, such a public registry of research 
uses  ultimately  allows  participants  to  withdraw  if  they 
disagree with the direction of the research. There are also 
other mechanisms of communication, such as bulletins 
and websites. Population studies recontact their partici­
pants for updates, or to take new measurements, thereby 
keeping ongoing consent alive and valid.
The most telling aspect of the developments described 
above, however, is that the underlying values presented 
here come from the current approaches promoted and 
used by the scientists and funders themselves. Concern 
for scientific integrity and mutual respect are then not 
imposed  by  legislative  or  professional  fiat  but  rather 
reveal  an  already  existing  shared  ethos  on  the  proper 
foundations for international science in the 21st century. 
This augers well for the future viability of the preliminary 
version of our proposed international data sharing Code 
of Conduct in genomic research (Box 1).
Conclusion
Addressing  the  issue  of  data  sharing  in  the  context  of 
international  genomic  research  requires  not  only  a 
holistic  approach,  but  also  the  fair  balancing  of  the 
interests, rights and duties of various stakeholders involved 
in collaborative endeavors. We have highlighted the need 
for  equitable,  ethical  and  efficient  access  to  data  and 
proposed a Code of Conduct (Box 1) that incorporates 
seven  principles:  quality,  accessibility,  responsibility, 
security,  transparency,  accountability  and  integrity.  We 
trust  that  this  code  will  foster  broader  discussion 
involv  ing multiple stakeholders.
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